Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
5(42%)
Results Posted
50%(2 trials)
Terminated
2(17%)

Phase Distribution

Ph not_applicable
1
8%
Ph phase_2
2
17%
Ph phase_4
1
8%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

5

trials recruiting

Total Trials

12

all time

Status Distribution
Active(6)
Completed(4)
Terminated(2)

Detailed Status

Completed4
Active, not recruiting3
Terminated2
Recruiting2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
5
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

completed433%
terminated217%
enrolling_by_invitation18%
recruiting217%
active_not_recruiting325%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12